Position in MYGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,209,132
+$591,548 QoQ
Shares Held
211,757
+54.3% QoQ
Ownership
0.221%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#50
of 197 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Voleon Capital Management LP holds $34,365,383 across 13 Diagnostics & Research names. MYGN ranks #6 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MTD |
Mettler Toledo International Inc/
|
8,346 | $10,662,098 | |
| 2 | GRAL |
GRAIL, Inc.
|
121,062 | $8,264,902 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
10,993 | $5,787,154 | |
| 4 | DHR |
Danaher Corp /De/
|
23,686 | $4,511,709 | |
| 5 | GH |
Guardant Health, Inc.
|
9,266 | $1,390,177 | |
| 6 | MYGN |
Myriad Genetics Inc
This page
|
211,757 | $1,209,132 | |
| 7 | MEDP |
Medpace Holdings, Inc.
|
1,729 | $915,661 | |
| 8 | PSNL |
Personalis, Inc.
|
26,502 | $355,126 |
All Filings in MYGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,209,132 | 211,757 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $617,584 | 137,241 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $423,150 | 68,805 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $828,022 | 114,526 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $364,414 | 68,628 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||